Glaukos Submits Supplemental PMA for iStent Infinite

September 7, 2021

0 Views

The iStent infinite is designed for use in a standalone procedure to reduce elevated intraocular pressure in patients with open-angle glaucoma uncontrolled by prior surgical or medical therapy.

Glaukos Submits Supplemental PMA for iStent Infinite

Emulate's Organ-on-Chip Technology in the 2nd Inning, Still Has Room to Grow

Fluidx Medical Introduces New Ultra Embolic Platform
Effective ‘People Strategy’ for Start-Ups
This Disappearing Heart Device Disappeared Altogether
Surviving the Headwinds in Medical Device Manufacturing
Medtronic Makes a Double Play for Atrial Fibrillation
Pulse Biosciences files 510(k) for CellFX nsPFA Percutaneous Electrode

Glaukos Submits Supplemental PMA for iStent Infinite

Medtech in a Minute: Elizabeth Holmes Heads to Trial, Baxter Bets Big on Hillrom, and More

Emulate's Organ-on-Chip Technology in the 2nd Inning, Still Has Room to Grow